Search research articles
Contact Us
Filters
Showing results (421-430 of 435) with videos related to
Page
of 44
Sort By:
Blood
|
June 30, 2026
TRANSFORM-1 Phase 3 study: Efficacy and safety of navitoclax plus ruxolitinib in patients with untreated myelofibrosis
Naveen Pemmaraju, Adam J Mead, Tim C P Somervaille, et al.
Nature Genetics
|
September 4, 2023
Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolution
Alba Rodriguez-Meira, Ruggiero Norfo, Sean Wen, et al.
Science (New York, N.Y.)
|
August 14, 2025
Platelets sequester extracellular DNA, capturing tumor-derived and free fetal DNA
Lauren Murphy, Jeanne Inchauspé, Giampiero Valenzano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2023
Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial
Claire N Harrison, Jyoti Nangalia, Rebecca Boucher, et al.
Biorxiv : the Preprint Server for Biology
|
December 18, 2023
Chromothripsis orchestrates leukemic transformation in blast phase MPN through targetable amplification of <i>DYRK1A</i>
C K Brierley, B H Yip, G Orlando, et al.
Leukemia
|
February 13, 2021
Results of a national UK physician reported survey of COVID-19 infection in patients with a myeloproliferative neoplasm
Richard A Salisbury, Natalia Curto-Garcia, Jennifer O'Sullivan, et al.
Nature Communications
|
November 24, 2023
Tamoxifen for the treatment of myeloproliferative neoplasms: A Phase II clinical trial and exploratory analysis
Zijian Fang, Giuditta Corbizi Fattori, Thomas McKerrell, et al.
Science Translational Medicine
|
October 9, 2024
A proinflammatory stem cell niche drives myelofibrosis through a targetable galectin-1 axis
Rong Li, Michela Colombo, Guanlin Wang, et al.
Nature Genetics
|
June 9, 2025
Chromothripsis-associated chromosome 21 amplification orchestrates transformation to blast-phase MPN through targetable overexpression of DYRK1A
Charlotte K Brierley, Bon Ham Yip, Giulia Orlando, et al.
Blood
|
January 10, 2022
A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia
John Mascarenhas, Heidi E Kosiorek, Josef T Prchal, et al.
Page
of 44
Search research articles
Search
Showing results (421-430 of 435) with videos related to
Sort By:
Page
of 44
Blood
|
June 30, 2026
TRANSFORM-1 Phase 3 study: Efficacy and safety of navitoclax plus ruxolitinib in patients with untreated myelofibrosis
Naveen Pemmaraju, Adam J Mead, Tim C P Somervaille, et al.
Nature Genetics
|
September 4, 2023
Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolution
Alba Rodriguez-Meira, Ruggiero Norfo, Sean Wen, et al.
Science (New York, N.Y.)
|
August 14, 2025
Platelets sequester extracellular DNA, capturing tumor-derived and free fetal DNA
Lauren Murphy, Jeanne Inchauspé, Giampiero Valenzano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2023
Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial
Claire N Harrison, Jyoti Nangalia, Rebecca Boucher, et al.
Biorxiv : the Preprint Server for Biology
|
December 18, 2023
Chromothripsis orchestrates leukemic transformation in blast phase MPN through targetable amplification of <i>DYRK1A</i>
C K Brierley, B H Yip, G Orlando, et al.
Leukemia
|
February 13, 2021
Results of a national UK physician reported survey of COVID-19 infection in patients with a myeloproliferative neoplasm
Richard A Salisbury, Natalia Curto-Garcia, Jennifer O'Sullivan, et al.
Nature Communications
|
November 24, 2023
Tamoxifen for the treatment of myeloproliferative neoplasms: A Phase II clinical trial and exploratory analysis
Zijian Fang, Giuditta Corbizi Fattori, Thomas McKerrell, et al.
Science Translational Medicine
|
October 9, 2024
A proinflammatory stem cell niche drives myelofibrosis through a targetable galectin-1 axis
Rong Li, Michela Colombo, Guanlin Wang, et al.
Nature Genetics
|
June 9, 2025
Chromothripsis-associated chromosome 21 amplification orchestrates transformation to blast-phase MPN through targetable overexpression of DYRK1A
Charlotte K Brierley, Bon Ham Yip, Giulia Orlando, et al.
Blood
|
January 10, 2022
A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia
John Mascarenhas, Heidi E Kosiorek, Josef T Prchal, et al.
Page
of 44